New Ambulatory Infusion Center for MG Patients Opens in Atlanta

Virtis Health center offers care for patient using specialty medications

Mary Chapman avatar

by Mary Chapman |

Share this article:

Share article via email
A close-up view of a patient's arm during an intravenous infusion treatment.

A new ambulatory center, operated by Virtis Health, has opened its doors in the Atlanta, Georgia, area for myasthenia gravis patients (MG) and others who require infusion treatments.

Virtis is a division of Soleo Health, a pharmacy that specializes in the provision of infusion therapies to homes or other care sites. It offers therapeutic and diagnostic services nationwide to those who have complex conditions like MG that require specialty infusible and injectable medications.

Together, Virtis and Soleo aim to provide patients with flexible care site options while meeting individual treatment needs. Two other ambulatory care centers in Ohio — one each in Columbus and Cleveland — also are being planned, Virtis announced last month.

Recommended Reading
Vyvgart | Myasthenia Gravis News | AAN beakers illustration

#AAN2022 – Long-term Vyvgart Eases gMG Symptoms

“The opening of the new Virtis Health Atlanta AIC [ambulatory infusion center], combined with Soleo Health’s complex specialty pharmacy services, affords the company yet another opportunity to extend its abilities and clinical expertise to bring highly personalized care to patients and providers alike,” Jennifer Joiner, regional vice president at Virtis, said in a press release.

“Since we offer additional resources and options in the community, we are confident our model will quickly become a preferred choice for the delivery of specialty infusible and injectable medications in the alternate care setting,” Joiner added.

Soleo is the U.S. distributor of Vyvgart (efgartigimod), an approved therapy for generalized MG (gMG), developed by Argenx. Other gMG therapies that require infusions include Soliris (eculizumab) and Ultomiris (ravulizumab), both originally developed by Alexion Pharmaceuticals.

The new center,  dubbed Virtis Health Atlanta, provides treatments and therapy management services to those who have autoimmune-related disorders, such as MG, multiple sclerosis, and chronic inflammatory demyelinating polyneuropathy. It also treats inflammatory conditions like Crohn’s disease, thyroid eye disease, rheumatoid arthritis, and ulcerative colitis, as well as primary immunodeficiencies and rare disorders.

The center, which accepts Medicare, Medicaid, and a broad range of private health insurance plans, is located at 1600 Oakbrook Drive, Suite 560B, in Norcross. It services those in the Atlanta area,  including residents of Dunwoody, Alpharetta, John’s Creek, Duluth, Lawrenceville, and Cumming.

Turquoise Holmes has been appointed nurse practitioner at the new center and will supervise the clinical practice. A former intensive care unit nurse, Holmes will manage patients’ needs and assess, diagnose, and treat general, as well as chronic conditions. The center also is staffed with clinical pharmacists.